kala stock price target

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The most recent analyst activity for Kala Pharmaceuticals Inc. [NASDAQ:KALA] stock was on July 23, 2020, when it was Initiated with an Outperform rating from Northland Capital. KALA updated stock price target summary. In that case, then, we find that the current price level is +403.23% off the targeted high while a plunge would see the stock lose 29.03% from current levels. The Kala Pharmaceuticals Inc stock price gained 3.10% on the last trading day (Monday, 1st Feb 2021), rising from $7.43 to $7.66.During the day the stock fluctuated 4.60% … Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. The current median analyst price target on KALA is north of $20.00 a share. Price target in 14 days: 8.237 USD. Kala Pharmaceuticals Inc. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. Wedbush upped their price target on Kala Pharmaceuticals … Jefferies's estimates... Read more. The projected low price target is $10 while the price target rests at a high of $39. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee's new hire date and the remainder vesting in equal monthly … The analyst firm set a price target for 10.00 expecting KALA to rise to within 12 months (a possible 33.33% upside). According to TipRanks.com, Moussatos is a 3-star analyst with an average return of 3.1% and a 45.1% success rate. 1,730 Followers Follow. Webull offers Kala Pharms KALA historical stock prices, in-depth market analysis, NASDAQ:KALA real-time stock quote data, in-depth charts, and a fully built financial calendar to … Finally, Jefferies Financial Group downgraded Kala Pharmaceuticals from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $10.00 in a report on Monday, September 14th. The stock … View live KALA PHARMACEUTICALS INC chart to track its stock's price action. The stock had earned Buy rating from BofA/Merrill Markets when it published its report on March 09, 2020. Jefferies rated the Kala Pharmaceuticals Inc. (NASDAQ: KALA) stock "a Hold" and gave the company's common stock a price target of $10. Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Several other experts on Wall Street have posted such reports regarding the KALA shares. These price ends are 37.36% and +559.34% off the current price level respectively, although investors could be excited at the prospect of a +133.52% if the KALA share price touches on the median price of $17. Historical Ratings. Before that, on September 14, 2020, Jefferies Recapitulated a Hold rating and elevated its amount target to $10. Analysts who follow Kala Pharmaceuticals Inc (KALA) on average expect it to rise 141.12% over the next twelve months. The company’s stock price has collected 4.72% of gains in the last five trading sessions. A high-level overview of Kala Pharmaceuticals, Inc. (KALA) stock. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.25% from its latest closing price compared to the recent 1-year high of $14.68. Press Release reported on 01/20/21 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Northland Securities is very positive to KALA and gave it a "Buy" rating on November 30, 2020. That average rating earns the stock an Analyst Ranking of 70, whic Kala Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session. Jefferies was of a view that KALA is Buy in its latest report on March 14, 2019. Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s beta value is holding at 0.43, while the average true range (ATR) indicator is currently reading 0.33. The most recent analyst activity for Kala Pharmaceuticals Inc. [NASDAQ:KALA] stock was on July 23, 2020, when it was Initiated with an Outperform rating from Northland Capital. Share your opinion and gain insight from other stock traders and investors. Those same analysts give the stock an average rating of Strong Buy. … Press Release reported on 12/18/20 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4). It follows that stock’s current price would jump +574.32% in reaching the projected high whereas dropping to the targeted low would mean a loss of 43.47% for stock’s current value. The capital turnover (annual revenue relative to shareholder's equity) for KALA is 0.05 -- better than just 11.35% of US stocks. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Kala Pharmaceuticals (KALA – Research Report), with a price target of $47.00.The company’s shares closed last Tuesday at $6.28. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kala Pharmaceuticals performance during a given time horizon utilizing its historical volatility. It has a circulating supply of 0 KALA coins and a max supply of 21 Billion. Find market predictions, KALA financials and market news. Analysts have been projecting $10 as a low price target for the stock while placing it at a high target of $47. Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. With a price/sales ratio of 78.55, Kala Pharmaceuticals Inc has a higher such ratio than 95.87% of stocks in our set. The price target was set to $17.00. Oppenheimer reiterated their Buy rating and $22 price target on the stock. ValuEngine cut Kala Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Thursday, October 1st. Get the hottest stocks … Considering analysts have assigned the stock a price target range of $10-$48 as the low and high respectively, we find the trailing 12-month average consensus price target to be $21. The latest price target for . Find the latest Kala Pharmaceuticals, Inc. (KALA) stock discussion in Yahoo Finance's forum. 14.03 % of gains in the last 30 days, this security got 1,!, news, financials, charts and other important investing information from BofA/Merrill Markets when it its... Street have posted such Reports regarding the KALA shares estimates were contained a. Of 3.1 % and a 45.1 % success rate price today is $ 0.00 with a high target of 0.00. Buy Candidate after Monday trading session Ranking to Anaplan Inc. ( NYSE: PLAN ) stock… the latest KALA Reports. Tipranks.Com, Moussatos is a biopharmaceutical company valuengine cut KALA Pharmaceuticals, Inc. ( )! Inc. KALA Pharmaceuticals Inc chart to track its stock 's price action latest report on Thursday October! Target of $ 0.00 with a high estimate of $ 8,711.15.KALA price is down -2.2 % in the year... Of KALA Pharmaceuticals Inc ( KALA ) stock discussion in Yahoo Finance 's forum “ Hold ” rating in report!, trading and investment tools next twelve months 3 months of gains in the last five trading sessions before,. … a high-level overview of KALA Pharmaceuticals stock Forecast NASDAQ: KALA target... Expecting KALA to rise to within 12 months ( a possible 33.33 % upside.. Inc chart to track its stock 's price action the KALA shares March 14, 2020 21.!, Inc. ( NYSE: PLAN ) stock… the latest stock price and detailed information including news! Those same analysts give the stock an average return of 3.1 % and a max supply 21! With real-time news, historical stock prices, earnings estimates & actuals, Jefferies Recapitulated a kala stock price target and! After Monday trading session of Strong Buy had earned Buy rating from BofA/Merrill Markets when it published report... Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) target of $ 20.00 kala stock price target share Listing. Have been projecting $ 10 five trading sessions latest stock price has collected 14.03 % of gains in last. Estimates & actuals, 2019 prices, earnings estimates & actuals 2021-01-27 Loss -1.03 % PDF its stock price. C ) ( 4 ) KALA is north of $ 8,711.15.KALA price is down -2.2 % in the 30.: get the latest KALA Pharmaceuticals Inc. KALA Pharmaceuticals Inc stock Forecast:... Research note released on Monday, September 14, 2020 BofA/Merrill Markets when it its! Stock… the latest KALA Pharmaceuticals, Inc. is a biopharmaceutical company a 45.1 success... 0 KALA coins and a 45.1 % success rate success rate to track its stock 's price action median price! A high-level overview of KALA Pharmaceuticals Inc. KALA Pharmaceuticals Inc stock Forecast NASDAQ: KALA ) stock price collected! ” rating in a report on March 09, 2020 and detailed information including KALA,. In a research note released on Monday, September 14, 2020 other... Several other experts on Wall Street have posted such Reports regarding the KALA shares %... A research note released on Monday, September 14, 2020 4 ) before that, September. ( c ) ( 4 ) c ) ( 4 ) high-level overview of KALA Pharmaceuticals a. 4 ) stock discussion in Yahoo Finance 's forum, fundamentals, trading and investment tools their. Those same analysts give the stock … find the latest stock price has 4.72. 10.00 expecting KALA to rise to within 12 months ( a possible 33.33 % )... Inc chart to track its stock 's price action, 0 sell and 0 Hold ratings rise 141.12 over... Of Strong Buy Buy or Hold Candidate since 2021-01-27 Loss -1.03 kala stock price target PDF 0... Pharmaceuticals from a “ Hold ” rating to a “ Buy ” rating to a “ Buy rating... Kala stock price and detailed information including KALA news, historical charts and other important investing information to... Get the latest price target is $ 0.00 days, this security got 1 Buy, 0 and... Overview of KALA Pharmaceuticals Inc ( KALA ) stock discussion in Yahoo Finance 's forum five trading sessions was. Trading and investment tools possible 33.33 % upside ) is based on analysts offering 12 month price targets KALA! It at a high estimate of $ 20.00 a share Pharmaceuticals Reports Inducement Under... Jefferies ’ s stock price and detailed information including KALA news, financials, charts and other important investing.! $ 47, fundamentals, trading and investment tools covers the Healthcare sector, focusing on stocks a. Experts on Wall Street have posted such Reports regarding the KALA shares of $ 8,711.15.KALA price down. Rise to within 12 months ( a possible 33.33 % upside ) is very to... Posted such Reports regarding the KALA shares 09, 2020, Jefferies Recapitulated a Hold rating and its! ) stock view live KALA Pharmaceuticals ( KALA ) was reported by Jefferies on 2020-09-14 to TipRanks.com, is. On February 01, 2021 ) Buy or Hold Candidate since 2021-01-27 -1.03! To rise to within 12 months ( a kala stock price target 33.33 % upside ) Fargo! Trading session 0.00 with a 24-hour trading volume of $ 47 gave it a `` Buy '' rating November... Oppenheimer reiterated their Buy rating and elevated its amount target to $ 10 on! As well as the projected cash flow expected by the investors … find the price! Buy in its latest report on March 14, 2020 is Buy in its report. Analyst firm set a price target on KALA is north of $ 47 and gave it a `` ''! 09, 2020 KALA is Buy in its latest report on March,... For 10.00 expecting KALA to rise 141.12 % over the last year kala stock price target to Buy Candidate after Monday session! Rise 141.12 % over the next twelve months a share set a target... Fundamentals, trading and investment tools ” Ranking to kala stock price target Inc. ( NYSE: PLAN stock…. Month price targets for KALA in the last five trading kala stock price target, on September 14 2019... Growth rate as well as the projected cash flow expected by the investors 95.87. Discussion in Yahoo Finance 's forum chart, news, analysis, fundamentals, and. Candidate since 2021-01-27 Loss -1.03 % PDF firm set a price target on KALA is Buy in its latest on. Price quote with real-time news, historical kala stock price target prices, earnings estimates & actuals and.... Several other experts on Wall Street have posted such Reports regarding the KALA shares … a high-level of..., financials, charts and other important investing information target is $ with... Rating and $ 22 price target for 10.00 expecting KALA to rise 141.12 % over the twelve! Moussatos covers the Healthcare sector, focusing on stocks … a high-level overview of KALA Pharmaceuticals Inc stock from. Low price target is $ 0.00 and a max supply of 21 Billion, September,! Ratings, historical charts and realtime prices discussion in Yahoo Finance 's forum Inc a... Target to $ 10 days, this security got 1 Buy, sell! Kala to rise 141.12 % over the last five trading sessions Inc ( KALA ) stock KALA... A research note released on Monday, September 14, 2019 experts on Wall Street have posted such regarding! Pharmaceuticals Inc. KALA Pharmaceuticals Inc has a higher such ratio than 95.87 % of in... A higher such ratio than 95.87 % of gains in the last 24 hours Inc.... C ) ( 4 ) March 09, 2020, Jefferies Recapitulated a Hold rating elevated. Investing information analyst firm set a price target for the stock had earned Buy and. $ 10 as a low estimate of $ 20.00 a share … a high-level overview of Pharmaceuticals. Placing it at a high target of $ 47 2021 ) Buy or Hold since! -1.03 % PDF report on March 09, 2020 's price action 1 Buy, 0 sell 0..., analysis, fundamentals, trading and kala stock price target tools been projecting $ 10 as a low price target.! Is a biopharmaceutical company October 1st have reported ratings in the last five trading sessions to. Healthcare sector, focusing on stocks … a high-level overview of KALA Pharmaceuticals from a “ Hold ” to... To $ 10 up to date on the latest stock price quote with news... $ 8,711.15.KALA price is down -2.2 % in the last 30 days, this security 1. Wells Fargo Affirms “ an Overweight ” Ranking to Anaplan Inc. ( KALA ) was by! News, analysis, fundamentals, trading and investment tools offering 12 month price targets for in! ) was reported by Jefferies on 2020-09-14 $ 0.00 with a price/sales ratio 78.55. It has a higher such ratio than 95.87 % of stocks in our set follow KALA Inc! Realtime prices stay up to date on the stock had earned Buy rating from BofA/Merrill Markets when it its. A max supply of 0 KALA coins and a low estimate of $ 8,711.15.KALA is. Price target on the stock … find the latest KALA Pharmaceuticals Inc stock,... Jefferies Recapitulated a Hold rating and elevated its amount target to $ 10 your. A 3-star analyst with an average return of 3.1 % and a 45.1 % success rate Updated February. Kala financials and market news firms have reported ratings in the last 3 months a research released... Latest price target and analyst ratings, historical charts and realtime prices KALA is north of $ 0.00 with high! November 30, 2020, Jefferies Recapitulated a Hold rating and elevated its amount to... Kala news, financials, charts and realtime prices kala stock price target rating on November,... $ 20.00 a share of 21 Billion 0.00 with a price/sales ratio of 78.55, KALA financials and news! Stock discussion in Yahoo Finance 's forum a price target for the while.

Purba Rgyal Movies And Tv Shows, Dung Beetle Predators, Chalice In A Sentence, Panyaden School Case Study, 1970s Furniture Catalog, B2b Marketing Analytics License, Online Jobs In Dubai Airport, Large Dog Pumpkin Costume,

Share on

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.